Mozobil recalls
Mozobil products have been recalled 2 times, most recently on 17 May 2017. The recalling company is usually Genzyme Corporation / Genzyme Biosurgery. The most common reason is packaging defects.
Total recalls2since 2016
Last 12 months0reported
Class I00% of total
Ongoing0latest 17 May 2017
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 2 100%
Why mozobil is recalled
Companies
Product types
By year
All mozobil recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Mozobil (plerixafor injection) 24mg/ (20mg/mL), For Single Use Only recalledMozobil | Sanofi-Aventis U.S | Packaging Defects | NJ |
| Drug | CLASS III | Mozobil (plerixafor injection) 24 mg/ (20 mg/mL) per vial recalledMozobil | Genzyme Corporation / Genzyme Biosurgery | Other | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.